Karen Todoroff

1.1k total citations
27 papers, 749 citations indexed

About

Karen Todoroff is a scholar working on Rheumatology, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Karen Todoroff has authored 27 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Surgery. Recurrent topics in Karen Todoroff's work include Folate and B Vitamins Research (14 papers), Pregnancy and preeclampsia studies (6 papers) and Congenital Anomalies and Fetal Surgery (5 papers). Karen Todoroff is often cited by papers focused on Folate and B Vitamins Research (14 papers), Pregnancy and preeclampsia studies (6 papers) and Congenital Anomalies and Fetal Surgery (5 papers). Karen Todoroff collaborates with scholars based in United States and Canada. Karen Todoroff's co-authors include Gary M. Shaw, Edward J. Lammer, Donna Schaffer, Ellen M. Velie, Lisa Croen, Richard H. Finnell, Steve Selvin, Rima Rozen, Gary Lerner and Dimitri G. Trembath and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Epidemiology.

In The Last Decade

Karen Todoroff

22 papers receiving 711 citations

Peers

Countries citing papers authored by Karen Todoroff

Since Specialization

Citations

This map shows the geographic impact of Karen Todoroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Todoroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Todoroff more than expected).

Fields of papers citing papers by Karen Todoroff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Todoroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Todoroff. The network helps show where Karen Todoroff may publish in the future.

Co-authorship network of co-authors of Karen Todoroff

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Todoroff. A scholar is included among the top collaborators of Karen Todoroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Todoroff. Karen Todoroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world analysis of pembrolizumab utilization and characteristics of patients being prescribed treatment in early stage RCC. 2025 ·Journal of Clinical Oncology ·Robert G. Uzzo, Rituparna Bhattacharya, Manojkumar Bupathi, Aymen Elfiky, (unknown), Karen Todoroff, Paul Conkling, Murali Sundaram	0
2	Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study 2025 ·Current Oncology ·(unknown), Manojkumar Bupathi, Valerie Morris, Paul Conkling, Karen Todoroff, (unknown), (unknown)	1
3	Real-world treatment pattern and clinical outcomes among patients with metastatic renal cell (mRCC) carcinoma post PD-1/PD-L1 immuno-oncology (IO) therapies. 2025 ·Journal of Clinical Oncology ·Neil J. Shah, Rahul Ravilla, (unknown), Karen Todoroff, (unknown), Pratik Rane, (unknown), Ding Wang, Robert J. Motzer	0
4	Real-World Baseline Characteristics and Preliminary Outcomes in Patients with Myelofibrosis Treated with Momelotinib in the US Community Oncology Practice Setting 2024 ·Blood ·Luke B. Fletcher, Nicole M. Niehoff, (unknown), (unknown), Karen Todoroff, William Zhang, (unknown)	0
5	Real-world (rw) treatment (tx) patterns and clinical outcomes in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC): Insights from The US Oncology Network electronic health record (EHR). 2024 ·Journal of Clinical Oncology ·Manojkumar Bupathi, (unknown), (unknown), Valerie Morris, Paul Conkling, Karen Todoroff, (unknown)	1
6	First-line maintenance use among patients with advanced ovarian cancer in a community oncology setting: A retrospective observational study in the United States (US). 2023 ·JCO Oncology Practice ·Dana M. Chase, Laura Iadeluca, Jonathan Lim, Wan‐Yu Tseng, (unknown), Karen Todoroff, Gregory W. Patton	0
7	Understanding the increased risk of neural tube defect‐affected pregnancies among Mexico‐born women in California: immigration and anthropometric factors 2006 ·Paediatric and Perinatal Epidemiology ·Ellen M. Velie, Gary M. Shaw, Lorraine Halinka Malcoe, Donna Schaffer, Steven J. Samuels, Karen Todoroff, Gladys Block	27
8	Lowered weight gain during pregnancy and risk of neural tube defects among offspring 2001 ·International Journal of Epidemiology ·Gary M. Shaw, Karen Todoroff, Suzan L. Carmichael, Donna Schaffer, Steve Selvin	24
9	Maternal Exposure to Nitrate from Drinking Water and Diet and Risk for Neural Tube Defects 2001 ·American Journal of Epidemiology ·Lisa Croen, Karen Todoroff, Gary M. Shaw	100
10	Periconceptional intake of vitamin supplements and risk of multiple congenital anomalies 2000 ·American Journal of Medical Genetics ·Gary M. Shaw, Lisa Croen, Karen Todoroff, M Tolarová	23
11	Maternal height and prepregnancy body mass index as risk factors for selected congenital anomalies 2000 ·Paediatric and Perinatal Epidemiology ·Gary M. Shaw, Karen Todoroff, Donna Schaffer, Steve Selvin	86
12	Prior Spontaneous Abortion, Prior Elective Termination, Interpregnancy Interval, and Risk of Neural Tube Defects 2000 ·American Journal of Epidemiology ·Karen Todoroff, Gary M. Shaw	39
13	Microsatellites proximal to leptin and leptin receptor as risk factors for spina bifida 2000 ·Teratology ·Gary M. Shaw, Robert C. Barber, Karen Todoroff, Edward J. Lammer, Richard H. Finnell	11
14	Spina bifida phenotypes in infants or fetuses of obese mothers 2000 ·Teratology ·Gary M. Shaw, Karen Todoroff, Richard H. Finnell, Edward J. Lammer	33
15	Analysis of select folate pathway genes,PAX3, and humanT in a midwestern neural tube defect population 1999 ·Teratology ·Dimitri G. Trembath, (unknown), (unknown), Gary M. Shaw, Karen Todoroff, Edward J. Lammer, Richard H. Finnell, (unknown), Gary Lerner, Jeffrey C. Murray	76
16	Maternal periconceptional use of electric bed-heating devices and risk for neural tube defects and orofacial clefts 1999 ·Teratology ·Gary M. Shaw, Verne Nelson, Karen Todoroff, Cathy R. Wasserman, Raymond Neutra	17
17	Maternal vitamin use, infant C677T mutation in MTHFR, and isolated cleft palate risk 1999 ·American Journal of Medical Genetics ·Gary M. Shaw, Karen Todoroff, Richard H. Finnell, Rima Rozen, Edward J. Lammer	2
18	Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip 1998 ·American Journal of Medical Genetics ·Gary M. Shaw, Rima Rozen, Richard H. Finnell, Karen Todoroff, Edward J. Lammer	93
19	Maternal illness, including fever, and medication use as risk factors for neural tube defects 1998 ·Teratology ·Gary M. Shaw, Karen Todoroff, Ellen M. Velie, Edward J. Lammer	124
20	Energy and Nutrient Intakes and Health Practices of Latinas and White Non-Latinas in the 3 Months Before Pregnancy 1998 ·Journal of the American Dietetic Association ·Donna Schaffer, Ellen M. Velie, Gary M. Shaw, Karen Todoroff	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact